CCT6A knockdown suppresses osteosarcoma cell growth and Akt pathway activation in vitro.
Weiquan ZengMeizhu WuYing ChengLiya LiuYuying HanQiurong XieJiapeng LiLihui WeiYi FangYouqin ChenJun PengA-Ling ShenPublished in: PloS one (2022)
We assessed the role of the protein-coding gene chaperonin-containing TCP1 subunit 6A (CCT6A) in osteosarcoma, as this is currently unknown. Using data from the R2 online genomic analysis and visualization application, we found that CCT6A messenger ribonucleic acid (RNA) expression is increased in osteosarcoma tissue and cells. Transfection of CCT6A small interfering RNA into cultured osteosarcoma cells revealed that CCT6A knockdown attenuates cell growth, cell viability, cell survival, and induced apoptosis and cell cycle progression at the G0/G1 phases. Moreover, CCT6A knockdown downregulated phospho-protein kinase B (p-Akt), cyclinD1 and B-cell lymphoma-2, whereas upregulated Bcl-2-associated X-protein expression. Thus, CCT6A knockdown inhibits cell proliferation, induces cell apoptosis, and suppresses the Akt pathway.
Keyphrases
- induced apoptosis
- signaling pathway
- cell proliferation
- cell cycle
- endoplasmic reticulum stress
- pi k akt
- oxidative stress
- cell cycle arrest
- protein kinase
- poor prognosis
- electronic health record
- binding protein
- healthcare
- copy number
- small molecule
- diffuse large b cell lymphoma
- amino acid
- social media
- long non coding rna
- health information
- endothelial cells
- protein protein
- artificial intelligence